GSK plc ADR (GSK)
NYSE
Closed
Oct 9, 2026
Day's Range
46.2752 wk Range
42.85Overview - GSK - GSK plc ADR
Key Statistics
Valuation
Enterprise Value
144.26B
P/E (Trailing)
‪14.83‬
P/E (Forward)
‪9.36‬
PEG Ratio
‪-0.21‬
Price / Sales (TTM)
‪2.83‬
Price / Book
‪4.03‬
EV / EBITDA
‪10.07‬
Profitability
Gross Margin
‪73.05%‬
Profit Margin
‪14.52%‬
Operating Margin
‪30.94%‬
Return on Assets
‪10.00%‬
Return on Equity
‪33.38%‬
Ownership
Shares Outstanding
4.00B
Float
1.94B
Short % of Shares Outstanding
‪0.73%‬
Held by Insiders
‪0.06%‬
Held by Institutions
‪17.47%‬
Price stats
Beta
‪0.29‬
50-Day Avg
‪50.62‬
200-Day Avg
‪52.42‬
Dividends
Payout Ratio
‪56.55%‬
Frequency
Quarterly
Analyst Consensus
8 analysts
Average price target
‪$ 60.51‬Shariah Compliance
Report Date: Feb 15, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - GSK - GSK plc ADR
Peers - GSK - GSK plc ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NYSE.
- GSKNYSEGSK plc ADR93.36BMarket Cap+6.97%52-week change14.84P/E (Trailing)‪14.52%‬Profit Margin
- LLYNYSEEli Lilly and Company1.05TMarket Cap+38.61%52-week change39.69P/E (Trailing)‪33.52%‬Profit Margin
- JNJNYSEJohnson & Johnson630.04BMarket Cap+26.98%52-week change30.25P/E (Trailing)‪21.48%‬Profit Margin
- ABBVNYSEAbbVie Inc.464.43BMarket Cap+12.41%52-week change73.62P/E (Trailing)‪9.80%‬Profit Margin
- MRKNYSEMerck & Co., Inc.359.22BMarket Cap+41.14%52-week change113.00P/E (Trailing)‪4.76%‬Profit Margin
- NVSNYSENovartis AG Sponsored ADR276.47BMarket Cap+14.68%52-week change21.97P/E (Trailing)‪22.50%‬Profit Margin
- SANNYSEBanco Santander, S.A. Sponsored ADR209.19BMarket Cap+28.64%52-week change14.28P/E (Trailing)‪33.46%‬Profit Margin
Profile Summary - GSK - GSK plc ADR
About
GSK plc ADR is an American depositary receipt representing two ordinary shares of GSK plc, a United Kingdom-based biopharmaceutical company. It provides U.S. investors with access to GSK’s healthcare business through a US-traded instrument tied to the company’s underlying ordinary shares. GSK focuses on…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
